MMR Injection – Complete Guide on Side Effects, Schedule, and Cost

The MMR injection protects against measles, mumps, and rubella — three highly contagious diseases. This guide covers the recommended schedule for children and adults, common side effects, dosage, and the cost of the vaccine in the UK, based on guidance from the NHS, UKHSA, and other health authorities.

What are the side effects of the MMR vaccine?

The MMR vaccine has an extensive safety record. Most side effects are mild and temporary, occurring in about 1 in 10 people. Serious adverse reactions are very rare.

Key insights

• The MMR vaccine prevents three serious diseases and is part of routine childhood immunisation in most countries.
• Two doses are required for full protection; the second dose is typically given before school entry.
• Adults without documented immunity or vaccination may need one or two doses, especially if at risk (healthcare workers, international travelers).
• Side effects are generally mild and temporary; the vaccine has an excellent safety record.
• Cost varies: free via public health systems (e.g., NHS), £40–£70 per dose privately in the UK.

Snapshot facts

Common (mild) side effects

These typically last 2–3 days and appear 7–11 days after the injection.

• Fever (mild)
• Blotchy rash similar to measles
• Sore or red arm at the injection site
• Swollen glands in the cheeks, neck, or jaw
• Joint pain or aching (2–3 weeks after vaccination)
• Irritability, fatigue, or general malaise

Rare but serious side effects

• Anaphylaxis (severe allergic reaction) — extremely rare
• Febrile seizures — very uncommon
• Temporary low platelet count (thrombocytopenia)

Extensive research has found no causal link between the MMR vaccine and autism. This was confirmed by multiple large-scale studies after a 1998 paper suggesting a link was retracted.

What is the MMR vaccine schedule?

Children (routine NHS schedule)

The standard childhood schedule requires two doses for optimal protection. The first dose is given around 12 months of age, and the second at around 3 years 4 months (or 18 months in some cases).

New MMRV schedule (from January 2026)

A newer vaccine called MMRV also protects against chickenpox (varicella). It will be offered under updated UK guidelines to children born on or after 1 January 2025. The first dose is given at 12 months, and the second at 18 months. Children born between July and December 2024 will receive their first MMRV dose at 18 months and the second at 3 years 4 months.

Adults

Adults born on or after 1957 who have no documented record of vaccination should receive at least one dose. Those at higher risk — including healthcare workers, international travelers, and women of childbearing age who are not pregnant — are advised to get two doses, spaced at least 4 weeks apart.

Adults born before 1957 without evidence of immunity should also consider two doses (at least 28 days apart), especially if they work in healthcare.

What is the MMR vaccine dose for adults and children?

Dose for children

Children receive the same standard dose as adults: 0.5 ml per injection. There is no reduced dose for younger patients.

Dose for adults

Adults receive the same 0.5 ml dose. The number of doses depends on risk and vaccination history. Those with no prior vaccination typically get one dose, with a second dose recommended for higher-risk groups.

How much does the MMR vaccine cost?

Cost depends on whether you access the vaccine through the NHS or a private provider.

MMR vaccine schedule and key milestones

1. 1963: First measles vaccine licensed (later combined as MMR in 1971).
2. 1988: MMR introduced in the UK as a single dose at 12 months.
3. 1996: Two-dose schedule adopted in the UK (second dose at 3–5 years).
4. 2004: MMRV vaccine (includes varicella) licensed in some countries.
5. 2025: Updated UK guidance recommending MMR for anyone born after 1970 without two documented doses.

What is certain and what remains unclear about the MMR vaccine?

Why does the MMR vaccine matter?

The MMR vaccine has dramatically reduced cases of measles, mumps, and rubella around the world since its introduction. Before vaccination, these diseases caused widespread illness, hospitalisations, and deaths. In the UK alone, measles cases fell from hundreds of thousands annually to near elimination after the vaccine was introduced.

Vaccine hesitancy, fuelled by a retracted and discredited 1998 study, led to a resurgence of measles in the 2000s. Public health campaigns have since restored confidence, but maintaining high coverage remains essential to prevent outbreaks, especially in under-vaccinated communities.

Current public health challenges include encouraging adults with incomplete vaccination status to catch up, particularly as measles cases rise globally. The introduction of the MMRV vaccine in the UK from 2025 represents an effort to simplify schedules and improve coverage.

What do official sources say about the MMR vaccine?

“The MMR vaccine is a safe and effective combined vaccine that protects against 3 separate illnesses – measles, mumps and rubella.”

— NHS UK

“The MMR vaccine is a live vaccine that protects against measles, mumps and rubella. 2 doses are given by injection into the leg or upper arm.”

— UK Health Security Agency (gov.uk)

“The measles-mumps-rubella (MMR) vaccine effectively prevents measles by stimulating the immune system to produce antibodies against the live-attenuated virus.”

— StatPearls (NCBI)

What should you know about the MMR injection next?

Check your vaccination record or ask your GP if you are unsure about your MMR status. If you need the vaccine, you can book an appointment through the NHS or a private clinic such as Superdrug or Boots. For travel, complete both doses at least two weeks before departure. If you experience a severe reaction, report it via the UK Yellow Card scheme.

Frequently asked questions